Your browser doesn't support javascript.
loading
DAXX-ATRX regulation of p53 chromatin binding and DNA damage response.
Gulve, Nitish; Su, Chenhe; Deng, Zhong; Soldan, Samantha S; Vladimirova, Olga; Wickramasinghe, Jayamanna; Zheng, Hongwu; Kossenkov, Andrew V; Lieberman, Paul M.
Afiliação
  • Gulve N; The Wistar Institute, Philadelphia, PA, 19104, USA.
  • Su C; The Wistar Institute, Philadelphia, PA, 19104, USA.
  • Deng Z; The Wistar Institute, Philadelphia, PA, 19104, USA.
  • Soldan SS; The Wistar Institute, Philadelphia, PA, 19104, USA.
  • Vladimirova O; The Wistar Institute, Philadelphia, PA, 19104, USA.
  • Wickramasinghe J; The Wistar Institute, Philadelphia, PA, 19104, USA.
  • Zheng H; Weill School of Medicine, Cornell University, New York, NY, USA.
  • Kossenkov AV; The Wistar Institute, Philadelphia, PA, 19104, USA.
  • Lieberman PM; The Wistar Institute, Philadelphia, PA, 19104, USA. lieberman@wistar.org.
Nat Commun ; 13(1): 5033, 2022 08 26.
Article em En | MEDLINE | ID: mdl-36028493
ABSTRACT
DAXX and ATRX are tumor suppressor proteins that form a histone H3.3 chaperone complex and are frequently mutated in cancers with the alternative lengthening of telomeres (ALT). Here, we show that DAXX and ATRX knock-out (KO) U87-T cells that have acquired ALT-like features have defects in p53 chromatin binding and DNA damage response. RNA-seq analysis revealed that p53 pathway is among the most perturbed. ChIP-seq and ATAC-seq revealed a genome-wide reduction in p53 DNA-binding and corresponding loss of chromatin accessibility at many p53 response elements across the genome. Both DAXX and ATRX null cells showed a depletion of histone H3.3 and accumulation of γH2AX at many p53 sites, including subtelomeres. These findings indicate that loss of DAXX or ATRX can compromise p53 chromatin binding and p53 DNA damage response in ALT-like cells, providing a link between histone composition, chromatin accessibility and tumor suppressor function of p53.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromatina / Histonas Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cromatina / Histonas Idioma: En Ano de publicação: 2022 Tipo de documento: Article